MARSHFIELD – Physicians with Marshfield Clinic Research Institute’s Cancer Care and Research Center were recognized for oncology clinical trial accruals sponsored by the National Cancer Institute.
Cancer Care and Research Center partnered with Gundersen Health System and ThedaCare to form the Wisconsin National Community Oncology Research Program (WiNCORP), which is a NCI-supported network that brings cancer prevention clinical trials and cancer care delivery research to people in their communities.
WiNCORP received the Platinum Award for excellence for exceptional patient enrollments, which is the highest level of recognition the program could have received.
“Clinical trials are an important tool in treating patients when their cancer defies conventional treatments,” said Adedayo Onitilo, M.D., Ph.D., Cancer Care and Research medical director. “Participating in a trial provides hope for a patient, which is an integral part of treatment. Successful clinical trials also potentially create hope and better survivorship odds for future cancer patients.”
Five Marshfield Clinic Health system oncologists received individual honors for exceptional patient enrollments for treatment and cancer control clinical trials over the past year.
Adedayo Onitilo (Weston, Stevens Point) – Platinum
- Isaac Yeboah (Marshfield) – Gold
- Seth Fagbemi (Marshfield) – Gold
- Patcharin Tanawattanacharoen (Eau Claire) – Silver
- Demet Gokalp Yasar (Minocqua) – Silver
The Health System participates in many clinical trials in different specialties, including more than 150 oncology clinical trials actively enrolling adult and pediatric patients.
As a member of WiNCORP, the Health System and its partners provide access to NCI-sponsored clinical trials to over 680,000 community members within its collective, largely rural, service area spanning most of Wisconsin, upper Michigan and adjacent counties in northern Iowa and southeastern Minnesota. WiNCORP has accrued nearly 1,300 people for clinical trials during the program’s history.